IDEXX LABORATORIES INC /DE Inventory
IDEXX LABORATORIES INC /DE (IDXX) had Inventory of $391.58 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryNet · last filed 2026-08-04
- 2026-06-30: Inventory, Net $391.58M.
- 2026-03-31: Inventory, Net $382.40M.
- 2025-12-31: Inventory, Net $377.76M.
- 2025-09-30: Inventory, Net $391.56M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $391.58M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $382.40M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $377.76M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $391.56M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $392.58M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $395.99M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $381.88M 10-K · filed 2026-02-20 |
| 2024-09-30 | $389.80M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $379.96M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $390.60M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $380.28M 10-K · filed 2025-02-21 |
| 2023-09-30 | $393.97M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $395.14M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $391.01M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $367.82M 10-K · filed 2024-02-22 |
| 2022-09-30 | $354.98M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $332.56M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $301.64M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $269.03M 10-K · filed 2023-02-16 |
| 2021-09-30 | $258.48M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $241.39M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $225.56M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $209.87M 10-K · filed 2022-02-16 |
| 2020-09-30 | $217.60M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $229.38M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $211.64M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $195.02M 10-K · filed 2021-02-12 |
| 2019-09-30 | $204.89M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $196.88M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $189.47M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $173.30M 10-K · filed 2020-02-14 |
| 2018-09-30 | $179.68M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $176.49M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $179.04M 10-Q · filed 2018-05-04 |
| 2018-01-01 | $163.18M 10-K · filed 2019-02-15 |
| 2017-12-31 | $164.32M 10-K · filed 2019-02-15 |
| 2017-09-30 | $176.75M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $169.69M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $172.18M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $158.03M 10-K · filed 2018-02-16 |
| 2016-09-30 | $168.47M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $175.69M 10-Q · filed 2016-08-02 |
| 2016-03-31 | $183.76M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $188.83M 10-K · filed 2017-02-17 |
| 2015-09-30 | $192.41M 10-Q · filed 2015-10-28 |
| 2015-06-30 | $184.50M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $173.37M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $160.34M 10-K · filed 2016-02-17 |
| 2014-09-30 | $156.01M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $145.40M 10-Q · filed 2014-07-25 |
| 2014-03-31 | $141.13M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $133.43M 10-K · filed 2015-02-17 |
| 2013-09-30 | $145.99M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $140.94M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $148.24M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $140.95M 10-K · filed 2014-02-18 |
| 2012-09-30 | $147.47M 10-Q · filed 2012-10-19 |
| 2012-06-30 | $143.70M 10-Q · filed 2012-07-20 |
| 2012-03-31 | $141.10M 10-Q · filed 2012-04-20 |
| 2011-12-31 | $133.10M 10-K · filed 2013-02-19 |
| 2011-09-30 | $137.14M 10-Q · filed 2011-10-21 |
| 2011-06-30 | $133.93M 10-Q · filed 2011-07-22 |
| 2011-03-31 | $127.05M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $127.89M 10-K · filed 2012-02-17 |
| 2010-09-30 | $131.56M 10-Q · filed 2010-10-22 |
| 2010-06-30 | $122.03M 10-Q · filed 2010-07-23 |
| 2009-12-31 | $110.42M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |